The U.S. Food and Drug Administration has approved a new oral treatment for psoriasis developed by Johnson & Johnson, offering patients a simpler and more convenient therapy option.
U.S.-based Merck & Co. has agreed to acquire Terns Pharmaceuticals in a $6.7 billion deal, as it looks to strengthen its cancer pipeline and reduce reliance on its blockbuster drug Keytruda.
.png "Rising Chemical Costs Squeeze Pharma Ingredient Producers")
India’s drug ingredient makers are facing a sharp rising chemical costs crisis, as surging prices of key inputs disrupt production and squeeze margins across the pharmaceutical supply chain.
As India’s healthcare landscape evolves with cutting-edge diagnostic solutions, Chennai is set to witness a transformative development in Alzheimer’s screening.
The World Health Organization (WHO) has introduced new guidance urging countries to improve how they prepare for health emergencies, with a stronger focus on regular simulation exercises and long-term planning rather than one-time drills.
The painkiller and antibiotic prices in India are set to rise slightly from April 1, following an annual revision linked to inflation.
With Semaglutide India versions hitting the market as the global weight loss and diabetes drug moves off patent, leading cardiology, endocrinology, and diabetology experts from Pune and Mumbai have issued a firm warning...
Zydus Lifesciences Limited has announced the launch of its Semaglutide injection in India under the brand names SEMAGLYN, MASHEMA, and ALTERME, following the expiry of the product’s patent.
The Delhi Health Budget 2026 allocates Rs 13,035 crore with focus on critical care, child healthcare, hospital expansion, and preventive services to improve access and early diagnosis.
India and Japan have signed a major agreement to invest JPY 275 billion in Maharashtra healthcare system, marking a significant step toward improving public health infrastructure in the state.
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")